Wealthfront Advisers LLC Purchases New Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Wealthfront Advisers LLC purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 370,126 shares of the health services provider’s stock, valued at approximately $3,364,000.

Several other hedge funds have also recently bought and sold shares of TDOC. Point72 Asset Management L.P. increased its holdings in shares of Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after purchasing an additional 3,063,172 shares during the period. Maple Rock Capital Partners Inc. acquired a new position in Teladoc Health in the 3rd quarter valued at approximately $11,291,000. Invenomic Capital Management LP lifted its position in Teladoc Health by 155.2% in the 3rd quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock worth $13,534,000 after buying an additional 896,552 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after buying an additional 424,180 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Teladoc Health by 18.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock valued at $22,213,000 after acquiring an additional 384,528 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

TDOC has been the subject of several recent research reports. Oppenheimer cut their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. Piper Sandler reduced their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. The Goldman Sachs Group cut their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $11.26.

Teladoc Health Price Performance

Shares of Teladoc Health stock opened at $8.50 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm has a fifty day moving average price of $10.60 and a two-hundred day moving average price of $9.68. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.68. The company has a market cap of $1.48 billion, a PE ratio of -1.47 and a beta of 1.27.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.